You are here

Roches

Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study

Endpoints

Thu, 08/22/19 - 11:54 am

Does Roche's Q3 flout diversification theory?

Fierce Pharma

Thu, 10/15/09 - 04:08 pm